값202020212022202320242025총 부채——————자본금 총액——————총 부채 및 주주자본——————총부채——————순부채——————
ProQR Therapeutics N.V. - Ordinary Shares
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.